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Abstract.  Gelsolin,  a  multifunctional  actin- 
modulating protein,  has two actin-binding  sites 
which may interact cooperatively. Native gelsolin re- 
quires micromolar Ca  2÷ for optimal binding of actin 
to both sites, and for expression of its actin fila- 
ment-severing function.  Recent work has shown that 
an NH2-terminal chymotryptic 17-kD fragment of hu- 
man plasma gelsolin contains one of the actin-binding 
sites, and that this fragment binds to and severs actin 
filaments weakly irrespective of whether Ca  2÷ is pres- 
ent.  The other binding site is Ca  2÷ sensitive, and is 
found in a chymotryptic peptide derived from the 
COOH-terminal  two-thirds of plasma gelsolin;  this 
fragment does not sever F-actin or accelerate the poly- 
merization of actin.  This paper documents that larger 
thermolysin-derived fragments encompassing the NH2- 
terminal half of gelsolin sever actin filaments as 
effectively as native plasma gelsolin,  although in a 
Ca2+-insensitive  manner.  This result indicates that the 
NH2-terminal half of gelsolin is the actin-severing do- 
main.  The stringent Ca  2÷ requirement for actin sever- 
ing found in intact gelsolin is not due to a direct effect 
of Ca  2÷ on the severing domain,  but indirectly through 
an effect on domains in the COOH-terminal half of the 
molecule to allow exposure of both actin-binding  sites. 
ELSOLIN is a Ca  2+- and actin-binding  protein first 
purified from the cytoplasm of rabbit lung mac- 
rophages (Yin and Stossel,  1979). A similar pro- 
tein called plasma actin depolymerizing factor was also 
identified in plasma (Chaponnier et al.,  1979; Norberg et 
al.,  1979). It is homologous to cytoplasmic gelsolin (Yin 
et al.,  1984), and has been called plasma gelsolin (Harris 
and Weeds, 1984; Harris,  1985; Coue and Korn, 1985) or 
brevin  (Harris  and  Schwartz,  1981; Doi  and  Frieden, 
1984; Lees et al.,  1984; Bryan and Hwo, 1985; Kilhoffer 
and Gerard,  1985).  Both cytoplasmic and plasma gelso- 
lins fragment actin filaments, nucleate actin filament as- 
sembly, and block their fast growing (+) ends. Of gelso- 
lin's actin-modulating functions, severing of filaments has 
the most  stringent  Ca  2+ requirement,  being completely 
abolished  in  its  absence (Yin  et al.,  1980;  Harris  and 
Weeds,  1983; Bryan and Coluccio,  1985; Janmey et al., 
1985).  Functional  studies indicate that gelsolin has two 
actin-binding  sites  (Yin  and  Stossel,  1980; Bryan  and 
Kurth,  1984) and indirect evidence suggests that they may 
bind  actin  in  a  cooperative manner  (Coue  and  Korn, 
1985; Harris,  1985; Janmey et al.,  1986b). After a 2:1 ac- 
tin/gelsolin complex is formed in the presence of Ca  2+ at 
a limiting actin concentration, removal of free Ca  2+ with 
EGTA releases actin from one site but not from the other, 
as reflected by the persistence of a 1:1 actin/gelsolin com- 
plex in EGTA (Bryan and Kurth,  1984; Kurth and Bryan, 
1984).  In macrophages,  an as yet undefined mechanism 
dissociates  this  EGTA-resistant  actin/gelsolin  complex 
(Chaponnier et al.,  1985). 
Structural  analyses  support the existence  of two distinct 
actin-binding  domains  in  human  plasma  gelsolin  (Kwiat- 
kowski et al., 1985). One actin-binding  site is found in a 17- 
kD  peptide  derived  from  the  extreme  NH2-terminus  of 
plasma gelsolin by chymotrypsin cleavage. This peptide 
binds to actin immobilized on Sepharose beads equally 
well in the presence of 0.2 mM CaCI2 or 1 mM EGTA. 
It binds to actin monomers in solution to form a 1:1 com- 
plex, and it can sever actin filaments. However, compared 
with  native  gelsolin,  its  severing  ability  is  decreased 
•100-fold  and is no longer regulated by Ca  2÷. The other 
actin-binding  domain  is  located  away  from  the  NH2- 
terminus in a 47-kD fragment generated by chymotrypsin 
digestion. It binds an actin monomer only in the presence 
of micromolar  Ca  2÷,  and  releases  the  actin  when  the 
Ca  2÷ concentration is decreased.  It does not sever actin 
filaments. Since intact gelsolin requires Ca  2÷ to sever ac- 
tin  filaments,  these observations raise  the questions  of 
why  severing  by the  small  NH2-terminal  fragment  no 
longer requires Ca  2÷ and why its ability to sever is de- 
creased. One possibility is that CT17 is part of a larger, 
more effective actin-severing domain which is Ca  2÷ sen- 
sitive. Alternatively, the severing domain may be inher- 
ently Ca  2÷ insensitive, and Ca  2÷ regulation is imposed on 
it by a  separate part of the protein. 
To  examine  these  possibilities,  larger  NH2-terminal 
actin-binding peptides were identified and their ability to 
sever actin filaments and to nucleate actin assembly in the 
presence  and  absence  of Ca  2÷  were  determined.  The 
NH2-terminal peptide has an Mr of 45,000 and is gener- 
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gelsolin.  It severs actin filaments as effectively as intact 
gelsolin but is no longer  regulated by  Ca  2÷.  The NH2- 
terminal peptide/actin complexes formed in the presence 
of Ca  2÷  retain  Ca  2÷  ions  which  cannot be  chelated  by 
EGTA.  We  conclude  that  the  NH2-terminal  half  of 
plasma  gelsolin  is  responsible  for  the  efficient  actin- 
fragmenting activity of gelsolin and for the formation of 
an  EGTA-irreversible  complex  with  actin.  Since  the 
NH2-terminal half peptide severs actin filaments even in 
the absence of Ca  2÷, the stringent Ca  2+ requirement for 
actin severing found in intact  gelsolin must be imposed 
on the NH2-terminal half by the COOH-terminal half of 
gelsolin, a region which contains a highly Ca2+-sensitive 
actin-binding site with no severing ability.  A  model for 
the interaction of the two halves of plasma gelsolin is also 
proposed by Bryan and Hwo (1985), except that their data 
suggest that  both actin-binding  sites  are  located  at  the 
NH2-terminal half of the molecule. 
Materials and Methods 
Purification of Plasma Gelsolin 
Human plasma gelsolin was prepared as described previously by conven- 
tional  column  chromatography  (Yin  and  Stossel,  1980) or  by  an  im- 
munoaffinity chromatographic method using the monoclonal anti-gelsolin 
antibody designated 2C4. IgG was purified from ascites fluid (prepared as 
described below) by DEAE Sepharose CL-6B chromatography, and coupled 
to cyanogen bromide-activated Sepharose CLAB beads (Pharmacia Fine 
Chemicals, Piscataway, NJ) at a ratio of 3 mg protein/ml packed beads. To 
affinity-purify plasma gelsolin, 300 ml human plasma was centrifuged at 
10,000 g for 30 min and passed over a column packed with 30 ml of 2C4 
antibody-Sepharose and equilibrated with 0.15 M NaC1, 20 mM Tris-HCl, 
pH 7.4 (TBS) containing 1 mM EGTA at 4°C. The column was washed se- 
quentially with 10 vol of TBS-EGTA, and 3 vol of TBS-EGTA containing 
1 M MgCI2.  Plasma gelsolin was eluted with TBS-EGTA containing 3 M 
MgC12, pH Z4.  Routinely,  '~20-30 nag of 90-95% pure gelsolin was re- 
covered by this procedure (see Fig. 3). The plasma gelsolin was dialyzed 
against TBS-EGTA and stored at -20°C in 40% glycerol. Plasma gelsolin 
prepared by this immunoaffinity procedure was functionally identical to that 
purified by conventional chromatography techniques, as judged by their 
ability  to  sever actin  filaments and  nucleate  actin  assembly  (Doi  and 
Frieden, 1984; Jamney and Stossel, 1986; Janmey et al., 1986a). Plasma gel- 
solin concentration was estimated using an extinction coefficient of A280 = 
1.538 cm  -I for a  l-mg/ml solution (Kilhoffer and Gerard,  1985).  In some 
cases, plasma gelsolin concentration was determined by the method of  Brad- 
ford (1976), using lgG as a  standard.  Parallel determinations with both 
methods show that they gave similar protein concentrations (within 10%). 
The extinction coefficient for plasma gelsolin was used to estimate the pro- 
rein content of purified NH2-terminal half and COOH-terminal half gelso- 
lin peptides. 
Production of MonoclonaI Antibodies 
8-wk-old BAL]3/c mice were injected intraperitoneally with 20 Ilg of human 
plasma gelsolin in complete Freund's adjuvant.  They were boosted 3 wk 
later with 20 I.tg plasma gelsolin in complete Freund's adjuvant, and subse- 
quently every 3  wk with antigen in incomplete Freund's adjuvant over a 
3-mo period. 3 d before fusion, the immunized mouse was boosted intrave- 
nously with  l0 ~tg of gelsolin in 0.15 M  NaCI solution. The mouse was 
killed by cervical dislocation and its spleen cells were fused with NS1 mouse 
myeloma cells (Kohter and Milstein, 1975; Oi and Herzenberg, 1980). Hy- 
bridomas producing antibody against gelsolin were screened by the solid= 
phase enzyme linked immunosorbent assay (ELISA) and positive clones 
were subcloned twice. Ascites fluid was produced by injecting cells into 
pristane-primed mice. The specificity of the monoclonal antibodies against 
gelsolin was assessed by immunoblotting with human plasma and human 
platelet extracts, after separation of proteins on SDS polyacrylamide gels. 
In each case, a single band co-migrating with either plasma or cytoplasmic 
gelsolin was detected (data not shown). 
Production of  Antibody against Synthetic Peptide 
The  NH2-terminal  amino acid  sequence of human plasma gelsolin has 
been published (Yin et al.,  1984). Based on this data, a synthetic peptide 
with a sequence consisting of the NHz-terminal 15 residues (Ala-Thr-Ala- 
Ser-Arg-Gly-Ala-Ser-Gln-Ala-Gly-Ala-Pro-Gln-Gly)  was generated by sol- 
id-phase technique, by the Peptide Synthesis Facility,  Children's Hospital 
Medical Center, Boston, MA. The peptide was desalted on a P-2 (Bio-Rad 
Laboratories, Richmond, CA) column equilibrated with 5% acetic acid. 10 
mg of  the peptide was coupled to 40 mg of  either keyhole limpet hemocyanin 
(Sigma Chemical Co., St. Louis, MO) or bovine serum albumin (BSA, ra- 
dioimmune assay grade; Sigma Chemical Co.) in a vol of 16 ml by dropwise 
addition of glutaraldehyde (2 %) to a final concentration of 0.1%.  The solu- 
tion was stirred for 1 h  at room temperature, and dialyzed exhaustively 
against saline. Rabbits were immunized by subcutaneous injection of 500 
Ixg peptide/keyhole limpet hemocyanin complex in complete Freund's adju- 
vent diluted with an equal volume of saline. After 1 mo, they were boosted 
three times at biweekly intervals with 200 ~tg protein in incomplete Freund's 
adjuvent. The presence of antibody against plasma gelsolin was determined 
by ELISA,  using microtiter plates coated with  10  I~g/ml human plasma 
gelsolin or  the  15-mer  synthetic peptide-BSA complex.  To  assess the 
specificity of the antibody against the  NH2-terminal peptide of human 
plasma gelsolin, the immune serum was tested against plates coated with 
the 15-mer peptide/BSA complex or human plasma gelsolin in the presence 
of 0-0.1  mg/ml of the peptide (without carrier). 
Proteolytic Cleavage of Plasma Gelsolin 
Human plasma gelsolin (0.6 mg/ml) was incubated with a-chymotrypsin 
(Worthington Biochemical Corp., Freehold, NJ) at a weight ratio of 230:1 
in TBS containing 2 mM MgCI2 and 0.2 mM CaC12. After 15 min at room 
temperature, freshly prepared phenylmethylsulfonyl fluoride (300  mM) in 
ethanol was added to a final concentration of I raM. Gelsolin was digested 
with thermolysin at wt/wt ratios ranging from 230:1  to 145,000:1, in TBS 
containing 2 mM MgC12 and 0.2 mM CaC12 for 15 min at room tempera- 
ture. The digests were analyzed on 5-15% or 5-20% discontinuous pH gra- 
dient slab gels by the method of Laemmii (1970). The apparent molecular 
weights of the peptides were estimated by comparison with the mobility of 
molecular weight standards (Bio-Rad Laboratories). 
lmmunoblotting of ProteolyticaUy Cleaved Peptides 
Gelsolin peptides resolved by PAGE in SDS were transferred to nitrocellu- 
lose sheets (BA 85; Schleicber & Schuell, Inc., Keene, NH) according to 
the method of Towbin et al. (1979). The blots were washed with TBS and 
blocked for 1 h with 3% BSA in TBS. They were then incubated with hy- 
bridoma supernatants at I:10 dilution in TBS containing 0.1% Triton X-100 
(TX) I and 3% BSA or polyclonal anti-N serum at a 100-fold dilution with 
TBS-TX-BSA for 2 h at room temperature or overnight at 4°C. The blots 
were washed with TBS-TX and incubated with the appropriate secondary 
antibody conjugated with horseradish peroxidase (either goat anti-mouse 
IgG or goat anti-rabbit IgG, Cappel Laboratories, Cochranville, PA) at a 
1:100-1:200 dilution in TBS-TX for I h at room temperature. The blots were 
then washed with three changes of TBS-TX, incubated with 0.5% TX in 
TBS for 30 min, and washed sequentially with three changes of TBS fol- 
lowed by 10 mM Tris-HCl, pH 7.4.  Horseradish peroxidase bound to the 
peptides was reacted with O-dianisidine and hydrogen peroxide (250 Ixg/ml 
and 0.075 %,  respectively) for  1-2  min, and the reaction was stopped by 
washing in TBS for 5 min. 
Binding of Gelsolin Peptides to Actin-Sepharose 
Actin was coupled to cyanogen bromide-activated Sepharose CL4B as de- 
scribed in Kwiatkowski et al., 1985. 10-15 ktg gelsolin or its cleaved products 
were incubated with 30 ~tl of actin-Sepharose in 200 I.tl of TBS-2 mM 
MgCI2  containing either 0.2  mM CaCI2 or  1 mM EGTA.  The samples 
were mixed constantly with an end-over-end mixer for 30 min at 10°C and 
washed with buffers containing either CaC12 or EG'TA, respectively. To de- 
termine if the peptides were bound irreversibly to the actin beads, pep- 
tide/actin bead complexes formed in the presence of 0.2 mM CaCI2 were 
washed extensively with TBS-EGTA.  Aliquots of proteins bound to the 
beads were analyzed on SDS polyacrylamide gels and, in some cases, elec- 
trophoretically transferred to nitrocellulose paper for staining with anti- 
bodies. 
1. Abbreviations used in this paper: DBP, vitamin D-binding protein; TX, 
Triton X-100. 
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9  p.g of gelsolin or gelsolin digests were incubated with 150  I.tl of ac- 
tin-Sepharose at 4°C in 458 txl TBS, 1.18 x  10 5 M total CaCl2, and 45Ca 
at a specific activity of 8.69 x  102 ~tCi/tlmol  with constant mixing. At the 
end of a 30-rain incubation, the beads were sedimented by centrifugation 
in an Eppendorf microfuge  and washed  twice with TBS-EGTA. The washed 
beads were incubated overnight at 4°C in TBS-EGTA to maximize elution 
of bound 45Ca, and collected on GFA filters set on a Multiphore filtration 
apparatus (Millipore Corp., Bedford, MA). The beads were covered with 
an additional filter, washed with 10 ml of TBS-EGTA, and counted in a 
Packard liquid scintillation  counter operating at 60% efficiency.  Actin beads 
incubated with 45Ca hut no gelsolin were included as a control. 
Interaction of  Peptides with Pyrene-labeled Actin 
G-actin, prepared by the method of Spudich and Watt (1971), was stored in 
a buffer containing 2 mM Tris-HCl, 0.2 mM CaCI2, 0.2 mM 2-mercapto- 
ethanol, 0.2 mM ATP, pH 7.6. It was labeled with N-(1-pyrenenyl)iodoacet- 
amide by the method of Kouyama  and Mihashi (1981). The relative amounts 
of G- and F-actin and the rate of change  of these quantities were determined 
as previously described Oanmey et al., 1985). In the presence of Ca  2+, the 
rate of actin polymerization in the presence of gelsolin has been shown to 
be proportional to the gelsolin concentration (Doi and Frieden, 1984; Jan- 
mey and Stossel, 1986), and when actin filaments are diluted to below the 
critical monomer concentration the depolymerization rate is proportional 
to the number of filament ends created by gelsolin (Bryan and Coluccio, 
1985; Coue and Korn, 1985; Janmey and Stossel, 1986). 
Results 
Specificity of  A n ti-gelsolin A n tibodies 
In  an  ELISA,  serum  from  a  rabbit  immunized  with  the 
plasma  gelsolin  NH2-terminus  15-mer  peptide/KLH  com- 
plex (anti-N-peptide antiserum) reacted positively with the 
same peptide coupled to a different carrier, BSA, as well as 
with plasma gelsolin. Binding of the anti-N serum to pep- 
tide/BSA and  plasma  gelsolin  was  reduced  75  and  85%, 
respectively, in  the presence  of 20  ~tg/ml of the  synthetic 
NH2-terminal  peptide  (without  carrier BSA)  antigen,  and 
100%  with 50 ~tg/ml of the antigen. BSA alone, which was 
present throughout the assay, did not block the binding of the 
antibody to the antigen or to plasma gelsolin. Specificity of 
the  anti-N  peptide  antibody  against  the  NH2-terminal 
residues of human plasma gelsolin was further ascertained 
by immunoblotting against chymotryptic peptides known to 
be derived from the NH2-terminus of plasma gelsolin (Fig. 
1). CT17 starts at residue 1 of plasma gelsolin while CT15 is 
offset by 23  amino acids, beginning at residue 24  (Kwiat- 
kowski et al.,  1985).  The anti-N serum reacted with CTI7 
but not C-'I'D. Since these two peptides were identical except 
for the absence of the synthetic peptide sequence in CTI5, the 
antibody is specific for the NH2-terminal peptide sequence 
of plasma gelsolin. 
Mapping of  Proteolytic Fragments of  Plasma Gelsolin 
Digestion  with Chymotrypsin.  It was  previously reported 
that chymotrypsin cleaves plasma gelsolin into two distinct 
actin-binding domains (Kwiatkowski et al.,  1985),, One do- 
main is at the amino-terminal 17-kD peptide portion and the 
other resides in a  47-kD peptide derived at least one-third 
of the  way  from  the  NH2-terminus.  In  this  report,  these 
chymotrypsin peptides were used to define the epitopes of 
anti-gelsolin antibodies which  were  in turn  used to locate 
other hitherto uncharacterized peptides containing these do- 
mains.  To maximize the yield of large fragments,  gelsolin 
was  digested  for  a  shorter  time  than  reported  previously. 
When such a chymotrypsin digest of gelsolin (Fig. 2 a, lane 
1 ) was incubated with actin beads in the presence of 0.2 mM 
CaC12,  a  47-,  45-,  and  17-kD  band  bound  to  actin  beads 
while a  31-kD band did not. The 45-kD band and the 17-kD 
band also bound to actin beads in the presence of EGTA. To 
sort out the relation between these peptides and distinguish 
between peptides with similar mobility on SDS gels but ap- 
parently  different  actin-binding  characteristics,  the  bands 
were analyzed by immunoblotting. The anti-N peptide anti- 
body reacted with the 45- and  17-kD peptides which bound 
to actin beads irrespective of the Ca  2+ concentration (Fig. 2 
b).  The  17-kD peptide is therefore identical to CTI7 which 
contains the NH2-terminal amino acid sequence  of plasma 
gelsolin  (Kwiatkowski  et  al.,  1985).  The  45-kD  actin- 
binding peptide which was also recognized by this antibody 
must contain the NH2-terminus and the NH2-terminal actin- 
Figure 1. Specificity  of the anti-N peptide antibody. EGTA-resistant 
CT17 and CH5 which were eluted from an actin-Sepharose column 
with acetic acid and sequenced as described previously (Kwiatkowski 
et al., 1985) were electrophoresed on an SDS polyacrylamide gel. 
One sample, containing 1 lag protein, was stained with Coomassie 
Blue (a), and the other, containing 0.33 lag protein, was blotted onto 
nitrocellulose paper and stained with the polyclonal rabbit anti-N 
peptide antibody. 
Figure 2. Effects of EGTA on the binding of chymotryptic peptides 
to actin-Sepharose. Aliquots of human plasma gelsolin digested with 
chymotrypsin in the presence of 0.2 mM CaCI2 at a wt/wt ratio of 
230:1  were incubated with actin-Sepharose in the presence of 0.2 
mM CaC12 (lanes 2) or 1 mM EGTA (lanes 3) and washed with 
the appropriate buffers.  Proteins bound to the beads were analyzed 
on an SDS polyacrylamide gel. (a) Coomassie Blue-stained gel. 
Lane 1, 2 I.tg  chymotrypsin digest. (b and c) Actin-binding peptides 
stained with anti-N peptide antiserum and 2C4 antibody, respec- 
tively. One third as much protein was loaded for immunoblotting 
as for Coomassie Blue staining. The M, (xl0  -3) of the chymotryp- 
sin peptides are indicated. 
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taining the NH2-terminal peptide of plasma gelsolin are la- 
beled with the suffix n. 
The anti-N peptide antibody did not recognize the 47-kD 
peptide, which on the basis of its Ca2+-dependent reversible 
binding to actin beads is equivalent to C1"47 (Kwiatkowski 
et al., 1985). This peptide, and a 45-kD peptide with similar 
actin-binding properties reacted with the monoclonal anti- 
body designated  2C4  (Fig.  2  c).  These two peptides  are 
therefore i'elated and contain the same actin-binding domain 
which is shown in Kwiatkowski et al.  (1985) to be derived 
from the carboxyl-terminal two-thirds of plasma  gelsolin. 
Using full-length sequence data for plasma gelsolin derived 
from cDNA cloning (Kwiatkowski et al.,  1986),  the origin 
of CT47 can be located precisely. The deduced amino acid 
sequence  shows  that plasma  gelsolin has  755  amino  acid 
residues and CT47 originates at residue 407, as indicated in 
Fig.  8. This places the site of chymotrypsin cleavage at the 
peptide bond between residues 406-407, which is approxi- 
mately in the middle of plasma gelsolin. The 31-kD peptide 
which does not bind actin begins at residue 151, suggesting 
that it is derived from CT45n after separation from the actin- 
binding CT17n. 
Digestion with Thermolysin.  Although CIq7n severs actin 
filaments, its activity is much weaker than that of intact gel- 
solin and  is  no longer regulated by Ca  2÷ (Kwiatkowski et 
al., 1985). To identify a domain with activity more compara- 
ble to that of intact gelsolin, the severing ability of the larger 
NH2-terminal half peptide was examined. Although chymo- 
trypsin  can  generate  the  two  gelsolin  halves,  it  readily 
cleaves the NH2-terminal half further to form smaller frag- 
ments (such as CT17n and CT31). Therefore, other proteases 
were used to digest gelsolin. Thermolysin gave a pattern of 
cleavage similar to that with chymotrypsin, but it did not de- 
grade the NH2-terminal half as readily. Consequently, using 
thermolysin, it is possible to cleave plasma gelsolin into its 
two halves quantitatively. 
Fig. 3 shows thermolysin first cleaved plasma gelsolin into 
two fragments with Mr's of 47,000 and 45,000, and subse- 
quently into smaller polypeptides.  The origin of some of 
these thermolysin peptides and their relation to the chymo- 
trypsin peptides could be deduced based upon their reactiv- 
ity towards  the  two antibodies described above and  their 
Ca  2+  requirement  for binding  to  actin.  TL47  and  TL45 
bound to actin beads in the presence of 0.2 mM CaC12 (Fig. 
4  a).  TL47 required Ca  2+ to bind actin and was  eluted by 
EGTA. TL45 was not detectibly affected by Ca  2+.  Anti-N 
peptide antibody recognized TL45, suggesting that it con- 
mined the NH2-terminal actin-binding site (Fig.  4  b) and 
was equivalent to CT45n. 2C4 antibody recognized a 47-kD 
and a minor 45-kD band which bound to actin beads only 
in the presence of CaCI2,  suggesting that they contained the 
actin-binding  site  located  in  the  COOH-terminal  half of 
plasma gelsolin and were equivalent to CT47c and CT45c, 
respectively.  These  results  showed  that  thermolysin,  like 
chymotrypsin, cleaved gelsolin into peptides of 45 kD con- 
taining the NH2-terminal actin-binding site of gelsolin and 
peptides of  47 and 45 kD containing the COOH-terminal half 
actin-binding site. 
Effect of Thermolysin-derived Gelsolin Fragments 
on F-actin 
The  effects  of  gelsolin  fragments,  generated  by  various 
degrees of thermolysin digestion, on the kinetics of F-actin 
depolymerization are shown in Fig. 5. In this depolymeriza- 
tion assay, the rate at which the actin filaments depolymerize 
when diluted to their critical concentration (with the resul- 
tant loss of pyrene fluorescence) is proportional to the num- 
ber of filament ends. In the presence of proteins such as gel- 
solin that block monomer exchange with the (+) filament 
Figure 3. Thermolysin cleaved products of human plasma gelsolin. 
Plasma gelsolin (0.63 mg/ml) was digested  with thermolysin  at weight 
ratios of 145,000:1 (lane 2),  29,000:1 (lane 3), 5,800:1 (lane 4), 
1,200:1 (lane 5), and 230:1 (lane 6) in TBS-2 mM MgC12-0.2 
mM CaC12 for 15 rain at room temperature. 2 ~tg of intact gelso- 
lin (lane 1) or gelsolin digests were analyzed on an SDS polyacryl- 
amide gel and stained with Coomassie Blue. MT (X10  -3) of protein 
standards (phosphorylase b, 94; bovine serum albumin, 68; oval- 
bumin, 45; carbonic anhydrase, 31; soybean trypsin inhibitor, 21; 
lysozyme, 15) are indicated on the left margin. 
Figure 4. Effect of EGTA  on the binding of thermolysin-cleaved  gel- 
solin peptides  to actin-Sepharose. Gelsolin  digested with thermolysin 
at a weight ratio 5,800:1 was incubated with actin-Sepharose beads 
in the presence of 0.2 mM CaCI2 (lanes 1 and 3) or 1 mM EGTA 
(lane 2).  The beads were washed with buffer containing 0.2 mM 
CaC12 (lane 1) or 1 mM EGTA (lanes 2 and 3). Proteins bound 
to the beads were resolved on an SDS polyacrylamide gel in tripli- 
cate. One set was stained with Coomassie Blue (a). The other two 
sets, containing  one third as much protein, were  blotted onto nitrocel- 
lulose papers and stained separately with anti-N antiserum (b) or 
2C4 antibody (c). 
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Figure 5.  Effects of thermoly- 
sin-digested gelsolin on F-ac- 
tin. Gelsolin samples digested 
with thermolysin (identical to 
those in Fig. 3) were diluted to 
a  final  concentration  of  7.7 
txg/ml (equivalent to 83 nM of 
plasma gelsolin)  in polymeriz- 
ing  buffer (2  mM  Tris-HCl, 
pH 7.6, 0.2  mM 2-mercapto- 
ethanol, 0.2 mM ATP, 2 mM 
MgCI2, and  150 mM KCI) con- 
raining either 0.2  mM CaC12 
(a)  or  1  mM  EGTA  (b)  at 
23°C.  Pyrene-labeled  actin 
was then added to a final con- 
centration of 38.7 txg/ml (900 
nM).  The rate of decrease in 
pyrene-actin  fluorescence, 
proportional to the fraction of 
polymerized  actin,  was  then 
measured  for  each  solution. 
Gelsolin digests generated with 
gelsolin/thermolysin  weight ra- 
tios of 145,000:1, 29,000:1, and 
5,900:1 (,) had similar activi- 
ty which was superimposable 
with that of undigested gelso- 
lin (.).  Gelsolin digested  with 
thermolysin (wt/wt ratios of 230:1) was indicated by <) and that with wt ratio of 1,200:1  had slightly lower activity than intact gelsolin 
(similar to ,x), and was omitted from the figure for the sake of clarity. The depolymerization of F-actin (without gelsolin) in the presence 
of an amount of thermolysin equivalent to the highest concentration present in the gelsolin digests was indicated by D. The effects of ther- 
molysin NH2-terminal peptides purified as described in Fig. 6 after digestion with thermolysin at wt/wt ratios of 5,800:1  (5.0 ~tg/ml,  111 
nM) and  1,200:1  (4.5  ~tg/ml,  100 nM) were indicated by •  and zx, respectively. 
ends,  this  critical  concentration  is  •0.7  ~tM,  and  the illa- 
ments depolymerize from their (-)  ends (Bryan and Coluc- 
cio,  1985;  Janmey et al.,  1985;  Cooper and Pollard,  1985; 
Mabuchi,  1983; Janmey and Stossel,  1986).  Plasma gelsolin 
which  had  been  cleaved  by  low  amounts  of  thermolysin 
(weight ratios of gelsolin to thermolysin of 145,000:1-5,800:1) 
into peptides in the range of 47--45  kD (Fig.  4,  lanes 2-4) 
retained all of the apparent filament-severing activity of in- 
tact gelsolin (Fig.  5 a). More extensive proteolysis (gelsolin 
to thermolysin weight ratio of 230:1) resulting in almost com- 
plete loss of cr45n decreased but did not eliminate the abil- 
ity to accelerate the depolymerization of F-actin. The sever- 
ing activity of the thermolysin peptides was not abolished in 
the presence of EGTA, in contrast to the dependence of intact 
gelsolin  on  Ca  2+  for  actin  filament  severing  (Fig.  5  b). 
Since there were equivalent amounts of gelsolin or gelsolin 
digests  in  each  assay,  these  data  suggest  that  the  larger 
thermolysin-derived  peptides  had  severing  activity  equiva- 
lent to that of intact gelsolin and the severing  function  was 
no  longer regulated  by Ca  2+ (Fig.  5  b). 
To identify the actin filament-severing peptide in the ther- 
molysin  digests,  NH2-terminal  half peptide  was  separated 
from the COOH-terminal half peptide by affinity chromatog- 
raphy. Thermolysin digests were passed over a 2C4-Sepha- 
rose column  to adsorb  specifically peptides  containing  the 
2C4 epitope. As shown in Fig. 6 a, the adherent fraction con- 
rains a major 47-kD and a minor 45-kD band, which by vir- 
tue of their ability to bind 2C4 but not anti-N peptide anti- 
body  (Fig.  6  b)  could  be  identified  as  TL47c  and  TIA5c, 
respectively.  The nonadherent  fraction  contained  mostly a 
45-kD band and in the more digested sample, a minor 31-kD 
and a  17-kD band (data not shown). The 45-kD band and the 
17-kD band  (not  shown)  reacted  with  anti-N  peptide  anti- 
body  (Fig.  6  b)  and  were  therefore  TL45n  and  TL17n, 
Figure 6. Separation of NH2- and COOH-terminal plasma gelsolin 
peptides by affinity chromatography. Plasma gelsolin (0.63 mg in 
1 ml) was digested with thermolysin (wt/wt ratio of 5,800:1) for 15 
min  and  passed  over a  column  containing  1.5  ml of 2C4  anti- 
body-Sepharose beads equilibrated with TBS-EG'rA. The nonad- 
herent  peptides  were  collected.  The  column  was  washed  with 
TBS-EGrA and adsorbed proteins were eluted with 3 M MgClz in 
TBS-EGTA. Aliquots from the nonadherent flow-through fractions 
(lanes 1) and adherent fractions (lanes 2) were analyzed on SDS 
polyacrylamide gels.  Peptides were stained with Coomassie Blue 
dye  (a)  or  immunoblotted  with  anti-N  peptide  antibody.  Mr 
(×10  -3) of peptides are indicated. 
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and COOH-terminal half fractions were estimated using the 
extinction coefficient reported for plasma gelsolin (Kilhoffer 
and Gerard, 1985).  This is justified because each half pep- 
tide contains similar mole percent of aromatic acids as intact 
plasma gelsolin (mole percents of tyrosine and tryptophan 
for plasma gelsolin are 2.0 and 2.9, respectively; for CT45n 
are 1.5 and 2.7, and for CT47c are 2.6 and 3.2) (Kwiatkowski 
et al.,  1986). 
In Fig. 5, the effect of two different affinity-purified  TL45n 
preparations on actin filaments is examined. In the presence 
of Ca  2+, TL45n fractions derived from digestion with ther- 
molysin (wt/wt ratios of 5,800:1  and 1,200:1)  had severing 
activity comparable to that of their respective unfractionated 
digests (Fig. 5 a). Based on these data, it can be inferred that 
the actin-severing function of gelsolin resides entirely in the 
NHz-terminal half of the  molecule.  Fig.  5  b  shows  that 
TL45n severed actin filaments in EGTA almost as effectively 
as it did in Ca  2÷, confirming that the NH2-terminal actin- 
severing domain of gelsolin is Ca  2+ independent. 
Gelsolin peptides from the COOH-terminal half (TL47c) 
had no effect on the rate of  depolymerization of F-actin when 
added at a similar weight ratio (data not shown). An effect 
on the final extent of polymerization only became apparent 
at close to equimolar amounts of the COOH-terminal pep- 
tides to actin (see below). 
Effects of Thermolysin-derived Gelsolin Fragments 
on Actin Polymerization 
The effects of NH2-terminal and COOH-terminal gelsolin 
fragments on the kinetics of actin polymerization are shown 
in Fig.  7.  In the presence of Ca  2÷, 6.2  ttg/ml thermolysin 
NH:-terminal peptides accelerated actin polymerization to 
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Figure  7.  Effects  of  thermolysin  NH2- and 
COOH-terminal half peptides on actin polymer- 
ization. Gelsolin digested with thermolysin at a 
wt/wt ratio of 1,900:1 for 15 rnin was fractionated 
through a 2C4-Sepharose  affinity column as de- 
scribed in Fig. 6. (a) The NH2-terminal peptides 
of gelsolin (6.2 Ixg/ml, 137 nM, 4), intact gelsolin 
(12.4 Ixg/ml, 133 nM, e), unfractionated gelsolin 
digest (12.4 ttg/ml, t), or thermotysin (an amount 
equivalent to that in the digests, o) were added to 
polymerizing  buffer  containing  1.2  mM  CaC12 
(left) or 0.2 mM CaC1J0.8 mM EGTA (right). 3.3 
ttM (142 ttg/ml) pyrene-labeled G-actin was added 
and the subsequent actin polymerization, propor- 
tional to the fluorescence, is shown as a function 
of  time. Fluorescence intensity is reported relative 
to a value of 1.0 for fully polymerized actin in the 
absence of gelsolin. (B) The COOH-terminal half 
peptides of gelsolin, TL47-45c (100 ttg/ml in poly- 
merizing buffer in the presence of pyrene-actin as 
above, m). Actin control (142 ktg/ml, 3.3 ttM, *). 
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less than 12.4 Ixg/ml of intact gelsolin (Fig. 7 a). In the pres- 
ence of EGTA, thermolysin NH2-peptides,  like the total di- 
gest, accelerated actin polymerization nearly eightfold more 
than intact gelsolin. 
In contrast, TL47c retarded the polymerization of actin 
and its effect was highly Ca  2÷ dependent. In the presence of 
Ca  2+, the rate was diminished and the final extent of poly- 
merization was lowered to an extent consistent with the for- 
mation  of  1:1  complexes  between  monomeric  actin  and 
TL47c. The effect of TL47c, like that of CT47c (Kwiatkowski 
et al., 1985), on actin polymerization was not detected until 
close to an equimolar amount of peptides was added to the 
actin. No effect on either the kinetics or extent of actin poly- 
merization was observed in the presence of EGTA, suggest- 
ing that the COOH-terminal actin-binding domain is regu- 
lated by Ca  2÷. 
Identification of an EGTA-resistant Ca  z+ within 
the Actin-NH2-Terminal Peptide Complex 
The EGTA-stable  1:1 actin/gelsolin complex contains a se- 
questered Ca  2+ (Bryan and Kurth,  1984). To determine if 
the EGTA-stable  actin/NH2-terminal peptides also contain 
nonexchangeable Ca  2+, complexes between affinity-purified 
NH2-terminal peptides and actin beads were formed in the 
presence  of  1.2  ×  10  -s  M  4sCaCl2, and the  beads  were 
washed extensively in EGTA. The actin bead assay detected 
Ca  2+ sequestered by plasma gelsolin/actin complexes (Table 
I, first line).  Under the conditions of the experiment, one 
mol of EGTA-resistant  Ca  2+ was bound to 2 tool of gelso- 
lin/actin complexed on the beads.  The explanation for the 
less than equimolar binding has not been determined. 45Ca 
was bound specifically to the gelsolin/actin bead complexes, 
because very little 45Ca was trapped in actin beads in the 
absence of gelsolin (fourth line). 
A chymotryptic digest of plasma gelsolin with peptides no 
larger than 47 kD retained 80%  of the EGTA-resistant  4SCa 
radioactivity relative to that found in intact gelsolin/actin 
complexes (second line).  The NH2-terminal actin-binding 
peptides in the flow-through fraction of the 2C4-Sepharose 
column also retained 45Ca when they were complexed with 
the actin beads.  Since this fraction contained two peptides 
capable of binding actin (CT45n and CT17n), and it is not 
known whether both species bound Ca  2÷ irreversibly when 
complexed with actin, it was not possible to calculate the 
number  of Ca  2+  atoms  bound  per  mol  of NH2-terminal 
actin-binding peptides.  However,  assuming that all of the 
actin-binding peptides in the sample were 45 kD,  1 mol of 
EGTA-resistant 45Ca was  estimated to be  associated with 
2.5 mol of actin/CT45n complex. A similar amount of 45Ca 
was retained when the flow-through fraction of thermolysin- 
digested gelsolin was tested in this assay (Table I, third line). 
These  data establish  that the  NH2-terminal  gelsolin pep- 
tide/actin complexes retain Ca  2÷,  even in the presence of 
EGTA. This technique could not be used to determine if the 
COOH-terminal peptide/actin complex might likewise retain 
45Ca, because it was eluted from the actin beads by EGTA. 
Consequently, 45Ca would not be expected to be retained on 
the beads,  as was  documented (Table  I,  second and third 
lines). 
Table L Presence of  EGTA-resistant 45Ca in Actin/Plasma 
Gelsolin Complexes 
Unfractionated*  Nonadherent~  Adherent§ 
epmll  cpm  cpm 
Intact gelsolin  54,560  +  50  --  -- 
Chemotrypsin digest  43,484  +  94  34,787  +  34  387  +  7 
Thermolysin digest  ND  34,174  +  44  423  +  4 
None  300  -  - 
* 9 ttg human plasma gelsolin or gelsolin digested with chymotrypsin (at wt/wt 
ratio of 380:1) or thermolysin (wt/wt ratio of 1900:1)  as described in Fig. 5 
were  incubated  with  actin-Sepharose  beads  in  the  presence  of 45Ca,  and 
washed subsequently in EGTA. 
$§ Gelsolin digests were passed over a  2C4 affinity  column as described in 
Fig. 6.4.5  I~g each of the nonadherent and adherent peptides were used per 
assay. 
II The 4~Ca bound to the beads were expressed in cpm, as mean +  SEM of 
duplicate samples. 
Discussion 
The data presented here support other evidence that the two 
actin-binding domains of plasma gelsolin are functionally 
distinct, both with respect to Ca  2÷ sensitivity and with re- 
spect to the ability to shorten actin filaments and nucleate ac- 
tin assembly. In addition, they show that the actin-severing 
domain of gelsolin is located entirely at the NH2-terminal 
half of gelsolin. In the presence of Ca  2÷, plasma gelsolin 
was readily cleaved in half by chymotrypsin or thermolysin 
to generate peptides containing the Ca2+-insensitive,  NH2- 
terminal  actin-severing  domain  and  the  Ca2+-sensitive, 
COOH-terminal  actin-binding  domain  with  no  severing 
function (Fig. 8).  The NH2-terminal half is cleaved further 
by these enzymes to generate a  17-kD and a  15-kD peptide 
containing the NH2-terminal actin-severing site and a 31-kD 
peptide with no actin-binding activity. The COOH-terminal 
half  of  plasma gelsolin is more resistant to further proteolysis 
(Kwiatkowski et al., 1985). Plasma gelsolin is not as readily 
cleaved in half in EGTA, suggesting that the cleavage site is 
less  accessible  in  the  absence of Ca  2+  (Bryan and Hwo, 
1986). 
The protease cleavage sites on the plasma gelsolin poly- 
peptide have been defined because the primary structure of 
the protein is now known, based on nucleotide sequence 
analyses of plasma gelsolin cDNA clones (Kwiatkowski et 
al.,  1986). These data also reveal that the two halves of the 
molecule have highly homologous amino acid sequences, 
particularly at the NH2-terminal portions of each half of the 
molecule.  Since  the  actin-binding  domain  of  the  NH2- 
terminal half is located close to its NH2-terminus (Kwiat- 
kowski et al., 1985), by inference, the homologous region in 
the NH2-terminal portion of the COOH-half may contain 
the other actin-binding domain. If  the two halves of  the mole- 
cule contain a duplicated actin-binding domain and yet have 
different actin-modulating properties, they are likely to have 
arisen from a gene duplication event, and diverged subse- 
quently to adopt their respective unique functions. 
The  NH2-terminal half peptide  of gelsolin severs  actin 
filaments as effectively as gelsolin, but it is no longer regu- 
lated by Ca  2+. These findings clearly establish that (a) the 
NH2-terminal actin-binding domain is responsible for the 
severing function of gelsolin; (b)  the NH2-terminal  17-kD 
fragment contains the actin-binding site, but the contiguous 
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Figure 8. A model of the primary structure of human plasma gelso- 
lin. The major peptides generated by chymotrypsin (CT) and ther- 
molysin (TL) cleavage in the presence of Ca  z+ are indicated. In the 
absence of Ca  2÷, the cleavage site in the middle of the molecule is 
less accessible to the enzymes. The regions containing the epitopes 
for anti-N and 2C4 antibodies are indicated by vertical arrows. The 
epitope of 2C4 was narrowed down to a 25-kD peptide at the NH2- 
terminus of CT47c (Kwiatkowski, D. J., unpublished data).  The 
numbers on top of the plasma gelsolin indicate apparent molecular 
mass (in kD),  estimated by comparison with the electrophoretic 
mobility of the peptides with molecular mass standards in SDS 
polyacrylamide gels. The amino acid residues, deduced from the 
primary sequence of plasma gelsolin, are indicated at the bottom. 
cDNA sequence analyses show that plasma gelsolin has a total of 
755 amino acid residues, with C1"45n  and CT47c accounting for 406 
and 349 residues, respectively. The molecular mass calculated from 
the deduced amino acid compositions of these peptides is 83 kD 
for plasma gelsolin, 45 kD for CT45n, and 38 kD for CT47c. The 
reason for the anomalous mobility of plasma gelsolin and CT47c 
on SDS polyacrylamide gels is not known, but for the sake of con- 
sistency, we have continued to refer to the M, of the peptides ac- 
cording to their apparent mobility on SDS gels. 
31 kD of the molecule, which by itself has no actin-binding 
ability, is required to promote optimal severing; (c) Ca  2÷ is 
not required for actin binding or severing by this domain. 
Since of all the interactions of gelsolin with actin, filament 
severing has the most stringent requirement for Ca  2÷ (Jan- 
mey et al.,  1985), the lack of a Ca  2÷ requirement by the iso- 
fated actin-severing domain suggests that in the intact mole- 
cule,  the  NH2-terminal-severing domain is  influenced by 
the  Ca2÷-regulated  COOH-terminal  half of the  molecule. 
This effect could presumably be exerted through a conforma- 
tional change of the COOH-half of the molecule to expose 
the NH2-terminal actin-binding site.  A  Ca2+-induced  con- 
formation change in plasma gelsolin is indicated by the fact 
that Ca  2÷ promotes the cleavage of gelsolin in the middle of 
the polypeptide (Bryan and Hwo, 1986),  increases the reac- 
tivity of gelsolin sulfhydryl groups towards 5,5' dithiobis(2- 
nitrobenzoic  acid)  (Kilhoffer  and  Gerard,  1985),  and 
decreases its sedimentation coefficient (Soua et al.,  1985). 
The  conformation of C1"47c changes  in  the  presence  of 
Ca  2÷, based on circular dichroism studies (Kwiatkowski et 
al., 1985). The overall change in the conformation of plasma 
gelsolin however must be sufficiently subtle to account for 
the findings that Ca  2÷ produced no changes in the circular 
dichroism (Kwiatkowski et al.,  1985) or tryptophan fluores- 
cence spectrum (Kilhoffer and Gerard, 1985) of the protein. 
Besides  severing actin filaments,  the NH2-terminal half 
peptide also accelerated the rate of polymerization of actin, 
but to a smaller extent than intact plasma gelsolin in the pres- 
ence of Ca  2+.  Actin assembly may be promoted by one of 
two mechanisms: (a) the actin/peptide complex may not it- 
self constitute a nucleus, but can trap an additional actin to 
form a  stable nucleus, as has been suggested for an Acan- 
thamoeba protein (Cooper and Pollard,  1985);  (b) the pep- 
tides provide nucleating sites secondarily through severing 
of actin filaments grown from spontaneously formed nuclei, 
as has been suggested for other actin-severing proteins iso- 
lated from starfish oocytes (Mabuchi, 1983), brain (Maeka- 
wa et al.,  1984),  and Acanthamoeba (Cooper et al.,  1986). 
The finding that the binding of the NH2-terminal domain 
to actin was not modulated by Ca  2+ provides an explanation 
for why the 1:1 actin/gelsolin complex is not dissociated by 
EGTA. The NHE-terminal peptide/actin complex retains a 
Ca  2÷ resistant to chelation by EGTA, as has been shown for 
the EGTA-resistant 1:1 actin/gelsolin complex. What is not 
clear at present is whether the Ca  2+ is associated with actin 
or the  NH2-terminal peptide.  Actin binds  Ca  2+ with high 
affinity and it may be induced to sequester Ca  2+ when com- 
plexed with gelsolin.  Gelsolin has two high-affinity Ca  2+- 
binding sites (Yin and Stossel, 1979; Bryan and Kurth, 1984). 
Since its COOH-terminal half is highly Ca  2÷ sensitive,  at 
least one of these sites should be present at that half of the 
molecule. Whether the NH2-terminal half also binds Ca  2+ 
remains to be determined. A search of the plasma gelsolin 
sequence for CaE÷-binding sites conforming to the EF-hand 
paradigm of calmodulin-like proteins (Kretsinger, 1980) re- 
veals a  potential site in the NH2-terminal half but not the 
COOH-terminal half of  plasma gelsolin (Kwiatkowski et al., 
1986). 
The COOH-terminal half peptide of gelsolin binds actin 
reversibly. When present at close to equimolar ratio with 
G-actin, it retards polymerization, apparently by sequester- 
ing  actin  monomers.  Therefore,  the  binary  complex  of 
COOH-terminal peptide and actin is not an effective actin 
nucleus. Furthermore, it does not sever actin filaments. Its 
major contribution to gelsolin function apparently lies in its 
ability to be regulated by Ca  2+ to influence the NHE-termi- 
nal domain of the molecule. 
In Fig.  8, we have integrated our structure and function 
data into a model for how gelsolin interacts with two actins 
in the presence of Ca  2÷ . Recent data suggest that binding of 
actin to the two sites may be cooperative, and binding is initi- 
ated at the CaE÷-sensitive actin-binding domain. In the pres- 
ence of Ca  ~+ and an equimolar or greater amount of gelso- 
lin  to  actin,  the  predominant  species  formed  is  the  2:1 
actin/gelsolin complex, as indicated by enhancement of actin 
fluorescence (Bryan and Kurth, 1984), equilibrium sedimen- 
tation (Coue and Korn,  1985),  and chemical cross-linking 
studies (Harris, 1985). A similar conclusion is also reached 
by Janmey et al. (1986b) using the plasma vitamin D-binding 
protein (DBP) to compete with gelsolin for actin. This actin 
monomer-sequestering protein prevents the formation of ei- 
ther  1:1  or 2:1  actin/gelsolin complexes, and extracts one 
monomer from preformed 2:1 actin/gelsolin complexes even 
in the presence of Ca  2÷. The resultant DBP-resistant 1:1 ac- 
tin/gelsolin complex cannot be dissociated by EGTA, sug- 
gesting that the same actin-binding site resists elution by both 
agents. The EGTA-irreversible NH2-terminal site therefore 
must have a  higher affinity for actin than DBP while the 
EGTA-reversible COOH-terminal  site  must  have  a  lower 
affinity for actin than DBP.  Since neither site binds actin in 
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the  higher  affinity  NH2-terminal  site must depend  on the 
prior occupation of the lower affinity Ca2+-sensitive COOH- 
terminal site. The possibly cooperative nature of the binding, 
and the fact that the Ca2+-sensitive  COOH-terminal  site is 
the first site to be occupied, explains why Ca  2+ is required 
for expression of the severing activity of gelsolin. 
Our  model  for plasma  gelsolin  structure  is different in 
several  respects  from that  proposed  by  Bryan  and  Kurth 
(1984) and Bryan and Hwo (1986).  They suggested that actin 
first binds to a high-affinity site which is relatively Ca  2+ in- 
sensitive, and then a lower affinity  site which is Ca  2+ sensi- 
tive and EGTA reversible. Occupation of the first actin site 
promotes  trapping  of a  Ca  2+  which  cannot  be  eluted  by 
EGTA, accounting for the persistence of a 1:1 actin/gelsolin 
complex in the presence of EGTA (Bryan and Kurth,  1984). 
Both actin-binding sites are located in a 40-kD peptide de- 
rived  from the  NH2-terminus  of plasma  gelsolin,  while a 
45-kD peptide, presumably derived from the COOH-termi- 
nal  half,  has  no  actin-binding  activity  but  contains  two 
Ca2+-binding sites (Bryan and Hwo, 1986).  The reasons for 
the discrepancies with our results are not clear. One possibil- 
ity is that due to the slightly different conditions used for pro- 
teolysis, the site of cleavage may not identical. This possibil- 
ity  can  be  investigated  by  determining  the  NH2-terminal 
amino acid sequence of the 40-kD peptide, as we have done 
for CT47c. Another possibility is that different actin-binding 
assays for gelsolin were used, and the less dramatic effect of 
substoichiometric amounts of CT47c on actin may have es- 
caped detection by the methods used by Bryan's group. De- 
spite these differences in detail, both models describe a high 
degree of coordination between the two halves of gelsolin to 
account for the Ca2+-regulated  actin-binding  properties of 
the intact  molecule. 
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